The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 28, 2017

Filed:

Jan. 11, 2016
Applicant:

Yale University, New Haven, CT (US);

Inventors:

Hee-Sung Park, Daejeon, KR;

Dieter Soll, Guilford, CT (US);

Assignee:

Yale University, New Haven, CT (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/67 (2006.01); C12P 21/02 (2006.01); C12P 21/00 (2006.01); C12N 9/00 (2006.01); C07K 14/245 (2006.01); C07K 14/435 (2006.01);
U.S. Cl.
CPC ...
C12N 15/67 (2013.01); C07K 14/245 (2013.01); C07K 14/435 (2013.01); C12N 9/93 (2013.01); C12P 21/00 (2013.01); C12P 21/02 (2013.01); C12Y 601/01027 (2013.01);
Abstract

Nucleic acids encoding mutant elongation factor proteins (EF-Sep), phosphoseryl-tRNA synthetase (SepRS), and phosphoseryl-tRNA (tRNA) and methods of use in site specific incorporation of phosphoserine into a protein or polypeptide are described. Typically, SepRS preferentially aminoacylates tRNAwith O-phosphoserine and the tRNArecognizes at least one codon such as a stop codon. Due to the negative charge of the phosphoserine, Sept-tRNAdoes not bind elongation factor Tu (EF-Tu). However, mutant EF-Sep proteins are disclosed that bind Sep-tRNAand protect Sep-tRNAfrom deacylation. In a preferred embodiment the nucleic acids are on vectors and are expressed in cells such as bacterial cells, archeaebacterial cells, and eukaryotic cells. Proteins or polypeptides containing phosphoserine produced by the methods described herein can be used for a variety of applications such as research, antibody production, protein array manufacture and development of cell-based screens for new drug discovery.


Find Patent Forward Citations

Loading…